« Previous Next » Psychiatry Research: Neuroimaging
Volume 173, Issue 2 , Pages 155-157 , 30 August 2009

Longitudinal 4.0 Tesla ³¹P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia

Jodi Miller
- Lawson Health Research Institute, London, Ontario, Canada
- Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
Peter Williamson
- Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
- Corresponding author. University Hospital- LHSC, 339 Windermere Rd., London, Ontario, Canada N6A 5A5. Tel./fax: +1 519 663 3935.
J. Eric Jensen
- Brain Imaging Center, McLean Hospital., Belmont, MA 02478, USA
Rahul Manchanda
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Ravi Menon
- Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
- Laboratory for Functional Magnetic Resonance Research, John P. Robarts Research Institute, London, Ontario, Canada
Richard Neufeld
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
- Department of Psychology, University of Western Ontario, London, Ontario, Canada
Nagalingam Rajakumar
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
William Pavlosky
- Department of Radiology and Nuclear Medicine, University of Western Ontario, London, Ontario, Canada
Maria Densmore
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Betsy Schaefer
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Dick J. Drost
- Lawson Health Research Institute, London, Ontario, Canada
- Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
- Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
- Department of Radiology and Nuclear Medicine, University of Western Ontario, London, Ontario, Canada

Received 18 January 2008 ,Revised 25 September 2008 ,Accepted 2 October 2008.

References

Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: The University of Iowa; 1984;
Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: The University of Iowa; 1984;
Bryden P. Measuring handedness with questionnaires. Neuropsychologia. 1977;15:617–624
- MEDLINE
- CrossRef
DeLisi LE. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophrenia Bulletin. 2008;34:312–321
- CrossRef
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-I. New York: American Psychiatric Publishing, Inc.; 1997;
Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research. 2006;81:47–63
- Abstract
- Full Text
- Full-Text PDF (372 KB)
- CrossRef
Jensen JE, Al-Semaan YM, Williamson PC, Neufeld RWJ, Menon RS, Schaefer B, et al. Region-specific changes in phospholipids metabolism in chronic, medicated schizophrenia. ³¹P-MRS study at 4.0 Tesla. British Journal of Psychiatry. 2002;180:39–44
Jensen JE, Drost DJ, Menon RS, Williamson PC. In vivo brain ³¹P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR in Biomedicine. 2002;15:338–347
- MEDLINE
- CrossRef
Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, et al. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. British Journal of Psychiatry. 2004;184:409–415
Ponder SL, Twieg DB. A novel sampling method for ³¹P spectroscopic imaging with improved sensitivity, resolution and sidelobe suppression. Journal of Magnetic Resonance, Series B. 1994;104:85–88
Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Pettegrew JW, et al. Regionally specific alterations in membrane phospholipids in children with ADHD: an in vivo ³¹P spectroscopy study. Psychiatry Research: Neuroimaging. 2006;148:217–221
Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry. 2006;188:510–518
Stevens J. Applied Multivariate Statistics for the Social Sciences. (3rd ed.). Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1996;
Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry. 2002;159:1944–1946
Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. American Journal of Psychiatry. 2003;160:2231–2233
Théberge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. The British Journal of Psychiatry. 2007;191:325–334
Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Archives of General Psychiatry. 2002;59:553–558
- MEDLINE
- CrossRef
Williamson P. In: Mind, Brain, and Schizophrenia. New York: Oxford University Press; 2006;p. 118–119
Vance DE. Phospholipid metabolism and cell signaling in eukaryotes. In: Vance DE, Vance JE editor. Biochemistry of Lipids, Lipoproteins and Membranes. Boston: Elsevier; 2008;p. 507–531
Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry. 2003;64:663–667